Folate status and neural tube defects
Authors:
- Anne M. MolloyAMAnne M. Molloy
- James L. MillsJMJames L. Mills
- Peadar N. KirkePKPeadar N. Kirke
- 1 January 1999
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 10 (2-3) , 291-294
Abstract
Periconceptional folic acid supplementation prevents approximately 70% of neural tube defects (NTDs). While most women carrying affected fetuses do not have deficient blood folate levels, the risk of having an NTD affected child is inversely correlated with pregnancy red cell folate levels. Current research is focused on the discovery of genetic abnormalities in folate related enzymes which might explain the role of folate in NTD prevention. The first candidate gene to emerge was the C677T variant of 5,10‐methylenetetrahydrofolate reductase. Normal subjects who are homozygous for the mutation (TT) have red cell folate status some 20% lower than expected. It is now established that the prevalence of the TT genotype is significantly higher among spina bifida cases and their parents. Nevertheless, our studies show that the variant does not account for the reduced blood folate levels in many NTD affected mothers. We conclude that low maternal folate status may in itself be the most important risk factor for NTDs and that food fortification may be the only population strategy of benefit in the effort to eliminate NTDs.Keywords
This publication has 14 references indexed in Scilit:
- Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: Low folate status alone may be the critical factorAmerican Journal of Medical Genetics, 1998
- Thermolabile variant of 5, 10-methylenetetrahydrofolate reductaseassociated with low red-cell folates: implications for folate intake recommendationsThe Lancet, 1997
- Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method1997
- Folate Levels and Neural Tube DefectsJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Homocysteine metabolism in pregnancies complicated by neural-tube defectsThe Lancet, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Maternal vitamin levels during pregnancies producing infants with neural tube defectsThe Journal of Pediatrics, 1992
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 1991
- Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects.Archives of Disease in Childhood, 1985